Aeterna Zentaris Inc. (AEZS)
NASDAQ: AEZS · IEX Real-Time Price · USD
5.85
-0.13 (-2.17%)
At close: Jul 19, 2024, 4:00 PM
5.73
-0.13 (-2.14%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Aeterna Zentaris Revenue
Aeterna Zentaris had revenue of $2.37M in the twelve months ending March 31, 2024. Revenue in the quarter ending March 31, 2024 was $4.00K. In the year 2023, Aeterna Zentaris had annual revenue of $4.50M.
Revenue (ttm)
$2.37M
Revenue Growth
-62.02%
P/S Ratio
7.54
Revenue / Employee
$197,833
Employees
12
Market Cap
17.91M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 4.50M | -1.14M | -20.25% |
Dec 31, 2022 | 5.64M | 380.00K | 7.22% |
Dec 31, 2021 | 5.26M | 1.61M | 44.03% |
Dec 31, 2020 | 3.65M | 3.12M | 586.47% |
Dec 31, 2019 | 532.00K | -26.35M | -98.02% |
Dec 31, 2018 | 26.88M | 25.96M | 2,812.35% |
Dec 31, 2017 | 923.00K | 12.00K | 1.32% |
Dec 31, 2016 | 911.00K | 366.00K | 67.16% |
Dec 31, 2015 | 545.00K | 534.00K | 4,854.55% |
Dec 31, 2014 | 11.00K | -6.16M | -99.82% |
Dec 31, 2013 | 6.18M | 4.12M | 200.78% |
Dec 31, 2012 | 2.05M | -2.65M | -56.37% |
Dec 31, 2011 | 4.71M | -23.00M | -83.02% |
Dec 31, 2010 | 27.70M | -35.53M | -56.19% |
Dec 31, 2009 | 63.24M | 24.76M | 64.35% |
Dec 31, 2008 | 38.48M | -3.59M | -8.53% |
Dec 31, 2007 | 42.07M | 3.27M | 8.43% |
Dec 31, 2006 | 38.80M | -6.01M | -13.42% |
Dec 31, 2005 | 44.81M | 1.84M | 4.28% |
Dec 31, 2004 | 42.97M | -75.77M | -63.81% |
Dec 31, 2003 | 118.74M | 40.81M | 52.37% |
Dec 31, 2002 | 77.93M | 44.22M | 131.18% |
Dec 31, 2001 | 33.71M | 27.24M | 420.84% |
Dec 31, 2000 | 6.47M | 1.73M | 36.49% |
Dec 31, 1999 | 4.74M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Biotricity | 12.06M |
VBI Vaccines | 9.41M |
Aspira Women's Health | 8.99M |
Synlogic | 3.21M |
Lyra Therapeutics | 1.68M |
Aptorum Group | 431.38K |
iBio, Inc. | 50.00K |
GlycoMimetics | 10.00K |
AEZS News
- 5 days ago - Aeterna Zentaris Announces Results of Virtual 2024 Meeting of Shareholders - GlobeNewsWire
- 5 weeks ago - Aeterna Zentaris Announces Last Patient Last Visit in Pivotal DETECT-Trial for the Diagnosis of Childhood-Onset Growth Hormone Deficiency - GlobeNewsWire
- 6 weeks ago - Shareholder Alert: Ademi LLP investigates whether Aeterna Zentaris Inc.'s transaction with Ceapro was Fair to Shareholders - PRNewsWire
- 6 weeks ago - Aeterna Zentaris and Ceapro Complete Merger Transaction - GlobeNewsWire
- 7 weeks ago - Aeterna Zentaris Provides Update on Timing for Annual Meeting of Shareholders and Due Bill Redemption Date - GlobeNewsWire
- 2 months ago - Aeterna Zentaris Announces Details Regarding Transaction with Ceapro - GlobeNewsWire
- 2 months ago - Aeterna Zentaris Reports First Quarter 2024 Financial Results - GlobeNewsWire
- 2 months ago - Aeterna Zentaris Announces Effective Date of Share Consolidation - GlobeNewsWire